These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 10065663)
41. Decreased Risk of Ischemic Heart Disease in Individuals with Severe Alpha 1-Antitrypsin Deficiency (PiZZ) in Comparison with the General Population. Tanash H; Ekström M; Basil N; Rönmark E; Lindberg A; Piitulainen E Int J Chron Obstruct Pulmon Dis; 2020; 15():1245-1252. PubMed ID: 32606637 [TBL] [Abstract][Full Text] [Related]
42. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD. Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072 [TBL] [Abstract][Full Text] [Related]
43. Factors associated with the evolution of lung function in patients with alpha-1 antitrypsin deficiency in the Spanish registry. Tirado-Conde G; Lara B; Casas F; Blanco I; Bustamante A; Cadenas S; Martínez MT; Lázaro L; Torres M; Hernández Pérez JM; Vidal R; Miravitlles M Arch Bronconeumol; 2011 Oct; 47(10):495-503. PubMed ID: 21798656 [TBL] [Abstract][Full Text] [Related]
44. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin]. Wencker M; Banik N; Buhl R; Seidel R; Konietzko N Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632 [TBL] [Abstract][Full Text] [Related]
45. Weight gain and longitudinal changes in lung function in steel workers. Wang ML; McCabe L; Petsonk EL; Hankinson JL; Banks DE Chest; 1997 Jun; 111(6):1526-32. PubMed ID: 9187168 [TBL] [Abstract][Full Text] [Related]
46. Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha 1-antitrypsin deficiency. Seersholm N; Kok-Jensen A Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):369-73. PubMed ID: 7842193 [TBL] [Abstract][Full Text] [Related]
47. A longitudinal study of alpha1-antitrypsin phenotypes and decline in FEV1 in a community population. Silva GE; Sherrill DL; Guerra S; Barbee RA Chest; 2003 May; 123(5):1435-40. PubMed ID: 12740258 [TBL] [Abstract][Full Text] [Related]
48. Heritability of lung function in severe alpha-1 antitrypsin deficiency. DeMeo DL; Campbell EJ; Brantly ML; Barker AF; Eden E; McElvaney NG; Rennard SI; Stocks JM; Stoller JK; Strange C; Turino G; Sandhaus RA; Silverman EK Hum Hered; 2009; 67(1):38-45. PubMed ID: 18931508 [TBL] [Abstract][Full Text] [Related]
49. The impact of smoke exposure on the clinical phenotype of alpha-1 antitrypsin deficiency in Ireland: exploiting a national registry to understand a rare disease. O'Brien ME; Pennycooke K; Carroll TP; Shum J; Fee LT; O'Connor C; Logan PM; Reeves EP; McElvaney NG COPD; 2015 May; 12 Suppl 1():2-9. PubMed ID: 25938284 [TBL] [Abstract][Full Text] [Related]
50. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. Chapman KR; Burdon JG; Piitulainen E; Sandhaus RA; Seersholm N; Stocks JM; Stoel BC; Huang L; Yao Z; Edelman JM; McElvaney NG; Lancet; 2015 Jul; 386(9991):360-8. PubMed ID: 26026936 [TBL] [Abstract][Full Text] [Related]
51. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression. Wise RA Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894 [TBL] [Abstract][Full Text] [Related]
52. Decline in FEV1 in patients with PiZ alpha-1-antitrypsin deficiency: the Australian experience. Burdon JG; Brenton S; Hocking V; Knight KR; Ayad M; Cook L; Janus ED Respirology; 2002 Mar; 7(1):51-5. PubMed ID: 11896901 [TBL] [Abstract][Full Text] [Related]
53. Intermediate alpha 1-antitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema? Seersholm N; Kok-Jensen A Respir Med; 1998 Feb; 92(2):241-5. PubMed ID: 9616519 [TBL] [Abstract][Full Text] [Related]
54. Long-range correlations of serial FEV1 measurements in emphysematous patients and normal subjects. Dirksen A; Holstein-Rathlou NH; Madsen F; Skovgaard LT; Ulrik CS; Heckscher T; Kok-Jensen A J Appl Physiol (1985); 1998 Jul; 85(1):259-65. PubMed ID: 9655784 [TBL] [Abstract][Full Text] [Related]
55. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan. Islam SS; Schottenfeld D Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576 [TBL] [Abstract][Full Text] [Related]
56. Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study. Oelsner EC; Balte PP; Bhatt SP; Cassano PA; Couper D; Folsom AR; Freedman ND; Jacobs DR; Kalhan R; Mathew AR; Kronmal RA; Loehr LR; London SJ; Newman AB; O'Connor GT; Schwartz JE; Smith LJ; White WB; Yende S Lancet Respir Med; 2020 Jan; 8(1):34-44. PubMed ID: 31606435 [TBL] [Abstract][Full Text] [Related]